Search Results 661-670 of 16856 for GLP-1 agonists

1. Gastrointestinal stromal tumor (GIST) - Doctors and departments - Mayo Clinic

   Departments and specialties. Mayo Clinic has one of the largest and most experienced practices in the United States, with campuses in Arizona, ...

2. A Study of MPDL3280A in Patients With Locally Advanced or Metastatic Urothelial Bladder Cancer - Mayo Clinic

   During the early phases (phases 1 ... Administration of a live, attenuated vaccine within 4 weeks before Cycle 1, Day 1 ... Prior treatment with CD137 agonists or ...

3. Endocrinology - Doctors - Mayo Clinic

   Mayo Clinic has one of the largest and most experienced practices in the United States, with campuses in Arizona, Florida and Minnesota. Staff skilled in ...

4. Hematology - Clinical trials

   ... 1 will be used followed by the target dose of ABBV-383. Avelumab In Combination Regimens That Include An Immune Agonist, Epigenetic Modulator, CD20 ...

5. Neurosurgery - Doctors - Mayo Clinic

   Mayo Clinic has one of the largest and most experienced practices in the United States, with campuses in Arizona, Florida and Minnesota. Staff skilled in dozens ...

6. A Study to Understand Clinical Reasoning Growth in Occupational and Physical Therapy Students’ when Participating in a Traditional or Collaborative Model in the Clinic

   About this study. The purpose of this study is to: 1. Understand the effects of individual versus group learning on occupational therapy students clinical ...

7. Gastroesophageal reflux disease (GERD) - Doctors and departments - Mayo Clinic

   Mayo Clinic has one of the largest and most experienced practices in the United States, with campuses in Arizona, Florida and Minnesota. Staff skilled in ...

8. Study Of Quemliclustat And Chemotherapy Versus Placebo And Chemotherapy In Patients With Metastatic Pancreatic Ductal Adenocarcinoma - Mayo Clinic

   ... 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market. Study IDs. Site IRB.

9. Dose Escalation and Expansion Study of GSK525762 in Combination With Fulvestrant in Subjects With Estrogen Receptor Positive (ER+) Breast Cancer - Mayo Clinic

   Approximately, up to 140 subjects and 154 subjects will receive study treatment in Phase I and Phase II respectively. A completed subject will be one who is ...

10. Neurology - Clinical trials

    This is a peripheral blood Collection Protocol to study the T-cell immune responses of patients with malignancies displaying one of three different patterns ...